An update on novel investigational agents for the treatment of primary biliary cholangitis
{{output}}
Introduction: Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by progressive bile duct destruction that can lead to liver cirrhosis and liver failure. While ursodeoxycholic acid (UDCA) remain... ...
